Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

A systematic approach is crucial for managing hair loss in women.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

New understanding and treatments for hair loss are improving, but more research is needed.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Minoxidil and finasteride effectively treat hair loss.